- Home
- IBIO vs EQS Comparison
IBIO vs EQS Comparison
Compare IBIO & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- EQS
- Stock Information
- Founded
- IBIO 2008
- EQS 1991
- Country
- IBIO United States
- EQS United States
- Employees
- IBIO N/A
- EQS N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- IBIO Health Care
- EQS Finance
- Exchange
- IBIO Nasdaq
- EQS Nasdaq
- Market Cap
- IBIO 15.9M
- EQS 19.0M
- IPO Year
- IBIO N/A
- EQS N/A
- Fundamental
- Price
- IBIO $0.81
- EQS $1.39
- Analyst Decision
- IBIO Strong Buy
- EQS
- Analyst Count
- IBIO 3
- EQS 0
- Target Price
- IBIO $4.87
- EQS N/A
- AVG Volume (30 Days)
- IBIO 5.4M
- EQS 10.9K
- Earning Date
- IBIO 05-02-2025
- EQS 01-01-0001
- Dividend Yield
- IBIO N/A
- EQS N/A
- EPS Growth
- IBIO N/A
- EQS N/A
- EPS
- IBIO N/A
- EQS N/A
- Revenue
- IBIO $375,000.00
- EQS $1,329,000.00
- Revenue This Year
- IBIO $36.00
- EQS N/A
- Revenue Next Year
- IBIO N/A
- EQS N/A
- P/E Ratio
- IBIO N/A
- EQS N/A
- Revenue Growth
- IBIO 650.00
- EQS 152.66
- 52 Week Low
- IBIO $0.64
- EQS $0.74
- 52 Week High
- IBIO $6.89
- EQS $1.52
- Technical
- Relative Strength Index (RSI)
- IBIO 47.34
- EQS 60.25
- Support Level
- IBIO $0.71
- EQS $1.35
- Resistance Level
- IBIO $0.87
- EQS $1.42
- Average True Range (ATR)
- IBIO 0.08
- EQS 0.04
- MACD
- IBIO 0.02
- EQS -0.01
- Stochastic Oscillator
- IBIO 37.39
- EQS 75.00
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.